Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
ISNA is a semi-official Iranian news agency (Iranian Students News Agency). This is a translation of that outlet's own report; it is the outlet's account, not Artesh's finding. See what Iranian state media is saying today.
❓ Unknown

Sales of 400 Trillion Rials in Pharmaceuticals in the First Half of This Year / Names of Best-Selling Drugs Announced

1w ago November 8, 2026 1 min read 📰 ISNA
📋 Key Takeaway

The Iranian pharmaceutical market saw a significant increase in sales, reaching 400 trillion rials in the first half of the year 1405, marking a 155% growth compared to the previous year. This highlights the growing demand and possibly inflationary pressures in the healthcare sector.

🔍 Quick Context Guide
💡 Bottom Line: The dramatic increase in pharmaceutical sales underscores the pressures on Iran's healthcare system and the economy.

👥 Key Players

Deputy Head of the Food and Drug Organization MENTIONED
Government official overseeing pharmaceutical regulation
"Responsible for monitoring and reporting on the pharmaceutical market, influencing healthcare policies and drug availability in Iran."

📰 What Happened

The Iranian pharmaceutical market reported sales of 400 trillion rials in the first half of the year 1405, a 155% increase from the previous year. This surge indicates rising demand and potential inflationary trends in the healthcare sector.

  • Total drug sales reached approximately 400 trillion rials.
  • This marks a 155% increase compared to 157 trillion rials sold in the same period last year.

💡 Why It Matters

🇮🇷 For Iran: The significant increase in pharmaceutical sales highlights both growing healthcare needs and the impact of inflation on drug prices, affecting access to medications.
🌍 Regional: Increased pharmaceutical sales may indicate broader economic instability in the region, potentially affecting neighboring countries reliant on Iranian pharmaceuticals.
🌐 International: The rise in sales could draw attention from international observers regarding Iran's economic resilience amid sanctions and its implications for global health.

📚 Background

Iran's pharmaceutical industry has been under strain due to economic sanctions and inflation, impacting drug availability and prices. Understanding this context is essential for grasping the significance of the sales figures.

Iranian economy and sanctions Healthcare access in Iran
📡 Source: STATE MEDIA
📊 Confidence: 70%
As a report from a government agency, it may emphasize positive developments while downplaying challenges in the healthcare sector.

The Deputy Head of the Food and Drug Organization outlined the performance of the country's pharmaceutical market in the first half of the year 1405, stating that the total rial sales of drugs during this period reached approximately 400 trillion rials, which shows a 155% increase compared to the 157 trillion rials sold in the same period last year.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →